• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清大内皮素-1是接受冠状动脉旁路移植术患者动脉僵硬度的重要生物标志物。

Serum big endothelin-1 is a significant biomarker of arterial stiffness in patients undergoing coronary artery bypass grafting.

作者信息

Jhan Jin-You, Lin Jian-Hong, Yang Kun-Ta, Hsu Bang-Gee, Chang Jui-Chih

机构信息

Division of Cardiovascular Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Institute of Medical Science, Tzu Chi University, Hualien, Taiwan.

出版信息

Sci Rep. 2025 Jul 1;15(1):21890. doi: 10.1038/s41598-025-08181-1.

DOI:10.1038/s41598-025-08181-1
PMID:40593258
Abstract

In the patients receiving coronary artery bypass grafting (CABG), arterial stiffness is an independent predictor of disease-related mortality. Higher serum levels of big endothelin-1 (BigET-1) are associated with arterial stiffness. The present study aimed to determine the association between serum BigET-1 levels and arterial stiffness in patients undergoing CABG. A total of 90 patients undergoing CABG were enrolled in the study. Serum levels of BigET-1 are examined with a commercial sandwich enzyme immunoassay. If carotid-femoral pulse wave velocity (cfPWV) > 10 m/s, arterial stiffness is diagnosed. In the study cohort, 30 (33.3%) patients with arterial stiffness were older and had lower body mass index, higher rates of diabetes mellitus and hypertension, higher systolic and diastolic blood pressures, and higher serum BigET-1 levels compared to the controls. Multivariable logistic regression analysis revealed that serum BigET-1 > 1 pg/mL was an independent predictor of arterial stiffness (odds ratio 17.492, 95% confidence interval 2.728-112.147, p = 0.003). Multivariable linear regression analysis revealed that cfPWV significantly correlated with age (β = 0.238, adjusted R change = 0.043, p = 0.004), systolic blood pressure (β = 0.251, adjusted R change = 0.102, p = 0.002), and BigET-1 level (β = 0.533, adjusted R change = 0.387, p < 0.001). Increased serum BigET-1 levels were associated with arterial stiffness in patients undergoing CABG.

摘要

在接受冠状动脉旁路移植术(CABG)的患者中,动脉僵硬度是疾病相关死亡率的独立预测因素。血清大内皮素-1(BigET-1)水平升高与动脉僵硬度相关。本研究旨在确定接受CABG患者的血清BigET-1水平与动脉僵硬度之间的关联。共有90例接受CABG的患者纳入本研究。采用商用夹心酶免疫测定法检测血清BigET-1水平。如果颈股脉搏波速度(cfPWV)>10 m/s,则诊断为动脉僵硬度。在研究队列中,与对照组相比,30例(33.3%)有动脉僵硬度的患者年龄更大、体重指数更低、糖尿病和高血压发生率更高、收缩压和舒张压更高,血清BigET-1水平也更高。多变量逻辑回归分析显示,血清BigET-1>1 pg/mL是动脉僵硬度的独立预测因素(比值比17.492,95%置信区间2.728-112.147,p = 0.003)。多变量线性回归分析显示,cfPWV与年龄(β = 0.238,调整后R变化 = 0.043,p = 0.004)、收缩压(β = 0.251,调整后R变化 = 0.102,p = 0.002)和BigET-1水平(β = 0.533,调整后R变化 = 0.387,p < 0.001)显著相关。接受CABG患者血清BigET-1水平升高与动脉僵硬度相关。

相似文献

1
Serum big endothelin-1 is a significant biomarker of arterial stiffness in patients undergoing coronary artery bypass grafting.血清大内皮素-1是接受冠状动脉旁路移植术患者动脉僵硬度的重要生物标志物。
Sci Rep. 2025 Jul 1;15(1):21890. doi: 10.1038/s41598-025-08181-1.
2
Elevated pulse wave velocity as a marker of arterial stiffness and its association with mortality in US adults.脉搏波速度升高作为动脉僵硬度的标志物及其与美国成年人死亡率的关联。
Sci Rep. 2025 Jul 2;15(1):23026. doi: 10.1038/s41598-025-07198-w.
3
Arterial Stiffness and Subsequent Incidence of CKD and Kidney Function Decline in a Large Longitudinal Community Cohort: The Atherosclerosis in Communities (ARIC) Study.大型纵向社区队列中动脉僵硬度与慢性肾脏病的后续发病率及肾功能下降:社区动脉粥样硬化风险(ARIC)研究
Am J Kidney Dis. 2025 Jul;86(1):32-42. doi: 10.1053/j.ajkd.2024.11.011. Epub 2025 Jan 23.
4
Factors associated with progression of arterial stiffness in ischemic stroke survivors: the Norwegian Stroke in the Young Study.与缺血性脑卒中幸存者动脉僵硬度进展相关的因素:挪威青年卒中研究。
Blood Press. 2024 Dec;33(1):2298308. doi: 10.1080/08037051.2023.2298308. Epub 2024 Jan 7.
5
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
6
Serum Indoxyl Sulfate as a Potential Biomarker of Peripheral Arterial Stiffness in Patients with Non-Dialysis Chronic Kidney Disease Stages 3 to 5.血清硫酸吲哚酚作为非透析慢性肾脏病3至5期患者外周动脉僵硬度的潜在生物标志物
Toxins (Basel). 2025 Jun 5;17(6):283. doi: 10.3390/toxins17060283.
7
Lower diastolic velocity in the internal carotid artery mediates lower cerebral blood flow with age.随着年龄增长,颈内动脉舒张期血流速度降低介导了脑血流量的减少。
J Appl Physiol (1985). 2025 Jun 1;138(6):1385-1397. doi: 10.1152/japplphysiol.00847.2024. Epub 2025 May 12.
8
Physiological serum uric acid concentrations correlate with arterial stiffness in a sex-dependent manner.生理血清尿酸浓度与动脉僵硬度存在性别依赖性关联。
BMC Med. 2025 Jul 1;23(1):356. doi: 10.1186/s12916-025-04195-8.
9
Associations of Central Arterial Stiffness With Brain White Matter Integrity and Gray Matter Volume in MRI Across the Adult Lifespan.成年期全生命周期中,MRI 检测的脑白质完整性和灰质体积与中心动脉僵硬度的相关性
J Magn Reson Imaging. 2025 Jan 10. doi: 10.1002/jmri.29713.
10
Arterial stiffness but not carotid intima-media thickness progression precedes premature structural and functional cardiac damage in youth: A 7-year temporal and mediation longitudinal study.动脉僵硬度而非颈动脉内膜中层厚度进展先于青年的过早结构性和功能性心脏损伤:一项 7 年时程和中介纵向研究。
Atherosclerosis. 2023 Sep;380:117197. doi: 10.1016/j.atherosclerosis.2023.117197. Epub 2023 Aug 4.

本文引用的文献

1
Arterial stiffness and hypertension.动脉僵硬度与高血压。
Clin Hypertens. 2023 Dec 1;29(1):31. doi: 10.1186/s40885-023-00258-1.
2
sST2 and Big ET-1 as Alternatives of Multi-Biomarkers Strategies for Prognosis Evaluation in Patients Hospitalized with Heart Failure.可溶性生长刺激表达基因2蛋白(sST2)和大内皮素-1(Big ET-1)作为心力衰竭住院患者预后评估多生物标志物策略的替代指标
Int J Gen Med. 2023 Nov 1;16:5003-5016. doi: 10.2147/IJGM.S435552. eCollection 2023.
3
Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis.
2 型糖尿病患者动脉僵硬度的决定因素:一项横断面分析。
Sci Rep. 2023 Jun 2;13(1):8944. doi: 10.1038/s41598-023-35589-4.
4
Aging of the Arterial System.动脉系统的老化。
Int J Mol Sci. 2023 Apr 7;24(8):6910. doi: 10.3390/ijms24086910.
5
Vascular Aging and Arterial Stiffness.血管老化与动脉僵硬度。
Arq Bras Cardiol. 2022 Oct;119(4):604-615. doi: 10.36660/abc.20210708.
6
Age and Serum Adipocyte Fatty-Acid-Binding Protein Level Are Associated with Aortic Stiffness in Coronary Artery Bypass Graft Patients.年龄和血清脂肪细胞脂肪酸结合蛋白水平与冠状动脉旁路移植术患者的主动脉僵硬度相关。
J Cardiovasc Dev Dis. 2022 Mar 31;9(4):105. doi: 10.3390/jcdd9040105.
7
Vascular Ageing Features Caused by Selective DNA Damage in Smooth Muscle Cell.血管衰老特征是由平滑肌细胞中选择性 DNA 损伤引起的。
Oxid Med Cell Longev. 2021 Aug 31;2021:2308317. doi: 10.1155/2021/2308317. eCollection 2021.
8
Arterial stiffness: A brief review.动脉僵硬度:简要综述。
Tzu Chi Med J. 2020 Sep 16;33(2):115-121. doi: 10.4103/tcmj.tcmj_44_20. eCollection 2021 Apr-Jun.
9
Biomarkers for the diagnosis and management of heart failure.心力衰竭的诊断和管理生物标志物。
Heart Fail Rev. 2022 Mar;27(2):625-643. doi: 10.1007/s10741-021-10105-w. Epub 2021 Apr 14.
10
Serum indoxyl sulfate as a potential biomarker of aortic arterial stiffness in coronary artery disease.血清吲哚硫酸酯作为冠状动脉疾病主动脉动脉僵硬的潜在生物标志物。
Nutr Metab Cardiovasc Dis. 2020 Nov 27;30(12):2320-2327. doi: 10.1016/j.numecd.2020.07.035. Epub 2020 Jul 31.